Development of a tissue array for primary melanoma with long-term follow-up: Discovering melanoma cell adhesion molecule as an important prognostic marker

Plastic and Reconstructive Surgery

Volumn 115, Issue 2, 2005, Pages 367-375

  Pacifico, Marc D ^a   Grover, Rajiv ^b   Richman, Paul I ^b   Daley, Frances M ^b   Buffa, Francesca ^b   Wilson, George D ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; CELL ADHESION MOLECULE; PARAFFIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA BASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL ADHESION MOLECULES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; STAINING AND LABELING; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 14044262349     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000148417.86768.C9     Document Type: Article

References (24)

1. Kirkwood, J. M., Ibrahim, J. G., Sosman, J. A., et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of intergroup trial E1694/S9512/C509801. J. Clin. Oncol. 19: 2370, 2001.
2. Balch, C. M., Soong, S. J., Gershenwald, J. E., et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19: 3622, 2001.
3. Morton, D. L., Wen, D. R., Wong, J. H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127: 392, 1992.
4. Hettiaratchy, S. P., Kang, N., O' Toole, G., Allan, R., Cook, M. G., and Powell, B. W. Sentinel lymph node biopsy in malignant melanoma: A series of 100 consecutive patients. Br. J. Plast. Surg. 53: 559, 2000.
5. Clark, W. H., Jr., Elder, D. E., Guerry, D., IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81: 1893, 1989.
6. Fearfield, L. A., Rowe, A., Francis, N., Fisher, C., Gore, M. E., and Bunker, C. B. Clinico-pathological features of relapsing very thin melanoma. Clin. Exp. Dermatol. 26: 686, 2001.
7. Salti, G. I., Kansagra, A., Warso, M. A., Ronan, S. G., and Das Gupta, T. K. Clinical node-negative thick melanoma. Arch. Surg. 137: 291, 2002.
8. Johnson, J. P. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 18: 345, 1999.
9. Hsu, M. Y., Meier, F. E., Nesbit, M., et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156: 1515, 2000.
10. Lehmann, J. M., Holzmann, B., Breitbart, E. W., Schmiegelow, P., Riethmuller, G., and Johnson, J. P. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res. 47: 841, 1987.
11. Luca, M., Hunt, B., Bucana, C. D.,Johnson, J. P., Fidler, I. J., and Bar-Eli, M. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res. 3: 35, 1993.
12. Xie, S., Luca, M., Huang, S., et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 57: 2295, 1997.
13. Kononen,J., Bubendorf, L., Kallioniemi, A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4: 844, 1998.
14. Mills, S. E., Kempson, R. L., Fechner, R. E., et al. Guardians of the wax... and the patient. Mod. Pathol. 8: 699, 1995.
15. Pacifico, M. D., Grover, R., Richman, P. I., et al. Validation of tissue microarray for immunohistochemical profiling of melanoma. Melanoma Res. 14: 39; 2004.
16. Schraml, P., Kononen, J., Bubendorf, L., et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin. Cancer Res. 5: 1966, 1999.
17. Drobnjak, M., Latres, E., Pollack, D., et al. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J. Natl. Cancer Inst. 86: 549, 1994.
18. Heslin, M. J., Cordon-Cardo, C., Lewis, J. J., Woodruff, J. M., and Brennan, M. F. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer 83: 490, 1998.
19. Thies, A., Moll, I., Berger, J., et al. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J. Clin. Oncol. 20: 2530, 2002.
20. Duncan, L. M., Deeds, J., Cronin, F. E., et al. Melastatin expression and prognosis in cutaneous malignant melanoma. J. Clin. Oncol. 19: 568, 2001.
21. Hieken, T. J., Farolan, M., Ronan, S. G., Shilkaitis, A., Wild, L., and Das Gupta, T. K. Beta3 integrin expression in melanoma predicts subsequent metastasis. J. Surg. Res. 63: 169, 1996.
22. Ostmeier, H., Fuchs, B., Otto, F., et al. Prognostic immunohistochemical markers of primary human melanomas. Br. J. Dermatol. 145: 203, 2001.
23. Kraus, A., Masat, L., and Johnson, J. P. Analysis of the expression of intercellular adhesion molecule-1 and MUC 18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen. Melanoma Res. 2: S75, 1997.
24. Shih, I. M., Speicher, D., Hsu, M. Y., Levine, E., and Herlyn, M. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res. 57: 3835, 1997.